SCHEMBL30178472

SCHEMBL30178472

CC(=O)OCn1cc(-c2cccc(F)c2Cl)c(=O)n(CCNC(=O)OC(C)(C)C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.36
GNRHR P30968 7/20 0.36
CYP3A4 P08684 5/20 0.36
IDO1 P14902 1/20 0.35
MALT1 Q9UDY8 1/20 0.35
SCN9A Q15858 1/20 0.35
TPSAB1 Q15661 1/20 0.35
TPSD1 Q9BZJ3 1/20 0.35
TPSG1 Q9NRR2 1/20 0.35
CAMK2D Q13557 1/20 0.34
PDPK1 O15530 1/20 0.34
CCNB2 O95067 1/20 0.34
PRKCB P05771 1/20 0.34
CDK1 P06493 1/20 0.34
LYN P07948 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3B P49841 1/20 0.34
RPS6KA3 P51812 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19873836 1.00 DRD2 (0.36) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL19873832 0.91 DRD2 (0.43) DRD2GNRHRCYP3A4MALT1TPSAB1
SCHEMBL30178348 0.89 GNRHR (0.41) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL17870723 0.89 GNRHR (0.41) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL28660744 0.88 GNRHR (0.40) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL19874027 0.83 GNRHR (0.36) GNRHRCYP3A4PDK2
SCHEMBL30178380 0.83 GNRHR (0.36) GNRHRCYP3A4PDK2
SCHEMBL17870746 0.83 MALT1 (0.38) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL30178450 0.83 GNRHR (0.34) DRD2GNRHRCYP3A4IDO1MALT1
SCHEMBL19873887 0.83 GNRHR (0.34) DRD2GNRHRCYP3A4IDO1MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3708566-B1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS GALDERMA RES & DEV (FR) 2023-02-08 EP disclosed